Cosmo Pharmaceuticals N.V. (COPN.SW)
SIX
Healthcare
Medical - Pharmaceuticals
$66.10
▼ -0.60%
Market Cap
$1.13B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.48
52-Wk Range
53.4-129.4
CEO
Giovanni di Napoli
Country
IE
Currency
CHF
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Open full interactive analysis & DCF →